Kegg medicus dgroup
| DG02863 | |
| DG番号 | DG02863 |
| 分類 | DGroup |
| 名称 | SLC22A2 inhibitor TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | DG00018 Ranitidine D00422 Ranitidine (USAN/INN) D00673 Ranitidine hydrochloride (JP18/USP) D05699 Ranitidine bismuth citrate (USAN) D00318 Famotidine (JP18/USP/INN) D00285 Co-Trimoxazole (BAN) DG00667 Dolutegravir D10066 Dolutegravir (USAN) D10113 Dolutegravir sodium (JAN/USAN) D10600 Dolutegravir, abacavir and lamivudine D11282 Dolutegravir sodium and rilpivirine hydrochloride D09731 Crizotinib (JAN/USAN/INN) D10927 Erdafitinib (JAN/USAN/INN) D06407 Vandetanib (JAN/USAN/INN) DG01107 Cetirizine D07662 Cetirizine (INN) D00664 Cetirizine hydrochloride (JP18/USP) DG01840 Isavuconazonium D10644 Isavuconazonium (USAN) D10643 Isavuconazonium sulfate (JAN/USAN) |
| 上位グループ | Transporter inhibitor |
| 注釈1 | - |
| 注釈2 | - |